{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:29:36Z","timestamp":1791822576766,"version":"4.3.4"},"reference-count":20,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1002\/ajh.70321","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:10:49Z","timestamp":1776485449000},"page":"1650-1653","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mixed Type Autoimmune Hemolytic Anemia: Clinical Severity and Treatment Patterns in a Large Observational Study"],"prefix":"10.1002","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2904-3840","authenticated-orcid":false,"given":"Francesco","family":"Versino","sequence":"first","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hematology Unit  Milan Italy"},{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-5676","authenticated-orcid":false,"given":"Uros","family":"Markovic","sequence":"additional","affiliation":[{"name":"Division of Hematology and BMT A.O.U. Policlinico \u2018G. Rodolico \u2013 San Marco\u2019  Catania Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto Luca","family":"Pedone","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hematology Unit  Milan Italy"},{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Pergolizzi","sequence":"additional","affiliation":[{"name":"Transfusion Medicine Unit, A.O.U. Policlinico \u2018G. Rodolico \u2013 San Marco\u2019  Catania Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hematology Unit  Milan Italy"},{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Barcellini","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hematology Unit  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[{"name":"Division of Hematology and BMT A.O.U. Policlinico \u2018G. Rodolico \u2013 San Marco\u2019  Catania Italy"},{"name":"Department of Surgery and Medical Specialties University of Catania  Catania Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fattizzo","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hematology Unit  Milan Italy"},{"name":"Department of Oncology and Hemato\u2010Oncology University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_2_1_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572\u2010024\u201000566\u20102"},{"key":"e_1_2_1_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2033982"},{"key":"e_1_2_1_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27721"},{"key":"e_1_2_1_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100648"},{"key":"e_1_2_1_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13753"},{"key":"e_1_2_1_8_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000540475"},{"key":"e_1_2_1_8_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206029"},{"key":"e_1_2_1_8_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201006\u2010583021"},{"key":"e_1_2_1_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25212"},{"key":"e_1_2_1_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26665"},{"key":"e_1_2_1_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014955"},{"key":"e_1_2_1_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022549"},{"key":"e_1_2_1_8_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2274912"},{"key":"e_1_2_1_8_15_1","unstructured":"\u201cA Multicenter Prospective Study of Iptacopan in the Treatment of Refractory\/Relapsed Autoimmune Hemolytic Anemia (AIHA) \u201dhttps:\/\/clinicaltrials.gov\/study\/NCT06847607."},{"key":"e_1_2_1_8_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010164"},{"key":"e_1_2_1_8_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2089115"},{"key":"e_1_2_1_8_18_1","volume-title":"Long\u2010Term Efficacy and Safety Study of Rilzabrutinib, Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA): LUMINA Phase 2b Part B","author":"Fattizzo B.","year":"2025"},{"key":"e_1_2_1_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000976904.28542.f2"},{"key":"e_1_2_1_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010206100"},{"key":"e_1_2_1_8_21_1","unstructured":"\u201cAn Open\u2010label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY\u20104) \u201dhttps:\/\/clinicaltrials.gov\/study\/NCT05757570."}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70321","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.70321","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:48:32Z","timestamp":1780386512000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.70321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/ajh.70321"],"URL":"https:\/\/doi.org\/10.1002\/ajh.70321","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2026-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}